If the death rate does not escalate and continues
Post# of 148190
(Total Views: 745)
Posted On: 10/22/2020 6:06:00 AM
If the death rate does not escalate and continues to be in decline, how will that influence our chances of meeting statical significance? There will be less deaths than at the beginning of the trial.
Will our p value at next interim be .05 or the more difficult one in the vicinity of .0029-.005?
NP said a preBLA meeting with UK would be happening very soon. He said a date this month How will that affect the stock price?
Will our p value at next interim be .05 or the more difficult one in the vicinity of .0029-.005?
NP said a preBLA meeting with UK would be happening very soon. He said a date this month How will that affect the stock price?
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼